期刊文献+

肾功能损害对血浆同型半胱氨酸浓度的影响 被引量:9

The effect of renal disfunction on plasma homocysteine
下载PDF
导出
摘要 目的研究不同肾功能患者血浆同型半胱氨酸(Hcy)浓度的变化特点及其与血浆肌酐和栓塞性心脑血管疾病(CVD)的关系,探讨其临床意义。方法采用快速高压液相微柱层析法测定中国人民解放军第455医院肾内科98例不同阶段慢性肾衰竭(CRF)患者及40例正常人的血浆Hcy浓度。结果CRF患者高Hcy血症的发生率高达86.7%,为正常对照组的33.3倍,P<0.01;并且血浆Hcy的浓度随着血肌酐浓度的升高或内生肌酐清除率(Ccr)的降低而升高,有明显的相关性,P<0.01。血液透析后(Post-HD)血浆Hcy水平较血液透析前(Pre-HD)下降约34.1%,但仍显著高于正常人,P<0.01。伴有栓塞性CVD组的血浆Hcy较无此病史者明显升高,P<0.01。结论不同阶段的CRF患者普遍存在高Hcy血症,并且肾功能损害的程度与Hcy浓度明显相关,CRF患者的高Hcy血症可能与其CVD有关。 Objective To study the effect of a various degree of renal disfunction on plasma homocysteine (Hcy) and its potential relationship to plasma creatinine concentration and cardiovascular diseases and probe into their clinical significance. Methods Plasma Hcy concentration in 98 patients with the various degree of chronic renal failure (CRF) and 40 healthy controls were measured by rapid microcolumn high pressure liquid chromatography in DS30. Results The incidence of hyperhomocysteinemia in the patients with CRF is 86.7% and 32. 3 times higher than that in healthy individuals, P〈0.01. Linear regression analysis showed a significant correlation between plasma Hcy and creatinine concentration (r=0. 358, P 〈0. 01) or creatinine clearance (r= 0.362, P 〈0.01). Mean plasma Hcy concentrations in post-HD decreased by 34.1% compared with that in pre HD and significantly higher than controls, P 〈 0.01. Mean plasma Hcy levels in CRF with cardiovascular (CVD) are significantly higher than that in the patients with non-CAD, P 〈0. 01. Conclusions Hyperhomocysteinemia is common in the patients with a various degree of CRF. Plasma Hcy concentration in CRF is significantly related to the degree of renal failure. Increased plasma Hcy may be a risk factor for CAD in the patients with CRF.
出处 《中国血液净化》 2005年第10期542-544,共3页 Chinese Journal of Blood Purification
关键词 慢性肾衰竭 同型半胱氨酸 血浆 心血管疾病 血液透析 Chronic renal failure Homocysteine Plasma cardiovascular diseasesHemodialysis
  • 相关文献

参考文献12

  • 1Chauveaμ P,Chadefaux B,Coude M,et al.Hyperhomocysteinemia,a resk factor for atherosclosis in chronic uremic patients.Kidney Iht,1993,43 (Suppl 41):S72-77
  • 2Bostom AG and Lathrop L.Hyperhomocycteinemia in end-stage renal disease:Prevalence,etiology,and potential relationship to arteriosclerotic outcomes.Kidney Int,1997,52:10-20
  • 3Bostom AG,Shemin D,Lapane KL,et al.Hyperhomocysteinmia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis case-control study.Atherosclosis,1995,114:93
  • 4Bostom AG and Culleton BF.Hyperhomocysteinemia in chronic renal disease.J Am Soc Nephrol,1999,10:891-900
  • 5D μ clo μ x D,Motte G,Challier B,et al.Serum total homocysteine and cardiovascular disease occurrence in chronic,stable renal transplant recipients:a prospective study.J Am Soc Nephrol,2000,11(1):134-137
  • 6田军,胡大勇,陆石,张金元,王颖,代干华.慢性肾衰竭血液透析患者血浆同型半胱氨酸的测定及其临床意义[J].中华内科杂志,2002,41(4):263-264. 被引量:8
  • 7余月明,侯凡凡,周华,杨燕,张训,杨凌,胡敏燕.慢性肾衰竭患者同型半胱氨酸血症与动脉粥样硬化的关系[J].中华内科杂志,2002,41(8):517-521. 被引量:22
  • 8Cockcroft DW,Gault MH.Prediction of creatinine clearance from serum creatinine.Nephron,1976,16:31-41
  • 9Foley RN,Parfrey PS,Sarnak MJ.Clinical epidemiology of cardiovascular disease in chronic renal disease.Am J Kidney Dis,1998,32 (Suppl 3):112-119
  • 10Desanto NG,Coppola S,Anastasio P,et al.Predicated creatinine clearance to assess glomerular filtration rate in chronic renal disease in humans.Am J Nephrol,1991,11:181-185

二级参考文献4

  • 1Bostom AG, Culleton BF. Hyperhomocysteinemia in chronic renal disease. J Am Soc Nephrol,1999,10:891-900.
  • 2Robinson K, Gupta A, Dennis V, et al.Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations.Circulation,1996,94:2743-2748.
  • 3Boushey CJ, Beresford SA, Omenn GS, et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.JAMA,1995,274:1049-1057.
  • 4许竹梅.超声检测动脉粥样硬化的进展:颈动脉内膜中层厚度的意义[J].心血管病学进展,1998,19(6):354-357. 被引量:49

共引文献27

同被引文献82

引证文献9

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部